Circulating BRAF(V600E) Levels Correlate with Treatment in Patients with Thyroid Carcinoma

Background: BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC) and can be associated with aggressive disease. Previously, a highly sensitive blood RNA-based BRAF(V600E) assay was reported. The objective of this study was to assess the correlation of BRAF(V600E) circulating...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thyroid
Autors principals: Lubitz, Carrie C., Zhan, Tiannan, Gunda, Viswanath, Amin, Salma, Gigliotti, Benjamin J., Fingeret, Abbey L., Holm, Tammy M., Wachtel, Heather, Sadow, Peter M., Wirth, Lori J., Sullivan, Ryan J., Panka, David J., Parangi, Sareh
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2018
Matèries:
Thyroid Cancer and Nodules
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865613/
https://ncbi.nlm.nih.gov/pubmed/29378474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2017.0322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars